Groups

                                                                 Parameters

Hb (g/dL)

RBC (106/µL)

HCT %

WBC (103/µL)

δ- ALAD in blood  (nmole/min/ml erythocyte)

Control

13.93  ±  0.19

7.36 ±  0.10

39.38 ±  0.66

5.12  ±  0.81

  9.14  ±  0.71

Cd-exposed

9.27  ±  0.55***

7.01 ±  0.08*

36.89 ± 0.43**

11.25  ±  1.31***

  3.55  ±  0.61***

Cd+Ceftriaxone plus sulbactam with VRP1034

11.22  ±  0.99**

7.20 ± 0.06 ns

37.78 ± 0.6*

7.84  ±  0.58**

  6.74  ±  0.50***
All data are Mean ± SD of each group. Newman keuls test was performed for statistical significance between control group vs Cd exposed group and Cd exposed group vs ceftriaxone plus sulbactam with VRP1034 treated group. Where ***p<0.001 (highly significant) **p<0.01(significant); *p<0.05 (significant) Nsp>0.05 (non significant).
Table 6: Effect of ceftriaxone plus sulbactam with VRP1034 on hematological and δ ALAD parameters in cadmium exposed group after 21 days treatment.